Literature DB >> 7787161

Immunoglobulin G subclass distribution of human anticolon antibodies in ulcerative colitis.

M Ohara1, T Hibi, N Watanabe, K Kobayashi, H Takaishi, A Hayashi, Y Hosoda, K Toda, Y Iwao, M Watanabe.   

Abstract

Immunoglobulin G (IgG) subclasses of anticolon antibodies were studied in patients with ulcerative colitis (UC) using enzyme-linked immunosorbent assay (ELISA). The concentrations of total serum IgG subclasses were also measured by ELISA. The values for total serum IgG subclasses in patients with UC were not significantly different from those in normal controls, while the ratio of IgG1 to IgG2 in the patients was significantly higher than that in normal controls. All four IgG subclasses of autoantibodies were demonstrated in the sera of the patients. IgG4 anticolon antibodies were detected most frequently (15 out of 18 patients, 83%). IgG2 was the next most prevalent (9 of 18 patients, 50%). The activity of anticolon antibodies in each subclass did not correlate with the concentration of the corresponding serum IgG subclass. Seven cell lines producing anticolon antibodies were obtained from the colonic mucosa of the patients by Epstein-Barr virus (EBV) transformation. IgG subclasses of anticolon antibodies secreted by these cell lines were also varied. IgG4 subclass was secreted by three EBV transformed cell lines, all of which produced IgG4 anticolon antibodies. These results suggest that all four different IgG subclasses could respond to the colon antigens and that various antigens in colonic mucosa or lumen may contribute to the induction of those autoantibodies. In addition, the prominence of IgG4 anticolon antibodies may support the pathogenic role of this subclass in UC as in other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787161     DOI: 10.1111/j.1440-1746.1995.tb01071.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Seiichi Kitagawa; Kenji Watanabe; Yasuhiro Fujiwara; Kazuhide Higuchi; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 2.  Macroprolactinemia: diagnostic, clinical, and pathogenic significance.

Authors:  Akira Shimatsu; Naoki Hattori
Journal:  Clin Dev Immunol       Date:  2012-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.